Methsuximide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Methsuximide. Educational only — not medical advice.
Labeled uses
Methsuximide is indicated for the control of absence (petit mal) seizures that are refractory to other drugs.
Source: FDA labeling via NIH DailyMed (set 5138e347…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.